Hayakawa, Mineji http://orcid.org/0000-0001-8341-7626
Tagami, Takashi
Kudo, Daisuke
Ono, Kota
Aoki, Makoto
Endo, Akira
Yumoto, Tetsuya
Matsumura, Yosuke
Irino, Shiho
Sekine, Kazuhiko
Ushio, Noritaka
Ogura, Takayuki
Nachi, Sho
Irie, Yuhei
Hayakawa, Katsura
Ito, Yusuke
Okishio, Yuko
Muronoi, Tomohiro
Kosaki, Yoshinori
Ito, Kaori
Nakatsutsumi, Keita
Kondo, Yutaka
Ueda, Taichiro
Fukuma, Hiroshi
Saisaka, Yuichi
Tominaga, Naoki
Kurita, Takeo
Nakayama, Fumihiko
Shibata, Tomotaka
Kushimoto, Shigeki
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Restrictive Red Blood Cell Transfusion Strategy for Critically Injured Patients (RESTRIC) trial: a cluster-randomized, crossover, non-inferiority multicenter trial of restrictive transfusion in trauma
https://doi.org/10.1186/s40560-023-00682-3
Funding for this research was provided by:
General Insurance Association of Japan
Marumo Emergency Medical Research Promotion Fund
Article History
Received: 12 June 2023
Accepted: 7 July 2023
First Online: 24 July 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study design was approved by the Ethics Committee of each participating institution (Additional file InternalRef removed) and that of the Japanese Association for the Surgery of Trauma. Written informed consent was obtained as soon as possible from the patients or their next-of-kin, after which the patients were enrolled in the trial. The trial was registered with the UMIN Clinical Trials Registry (UMIN000034405) on October 8, 2018.
: Not applicable.
: The authors declare that they have no competing interests.